Junior global health major Hope Arcuri came to Duke before she knew she was interested in global health. Drawn to Duke’s public policy program, Arcuri soon realized she wanted to delve deeper into the ways in which policy could impact poverty and health.
Thirty-seven DGHI-affiliated authors—including faculty, staff and alumni—recently shared new discoveries on a variety of global health topics in peer-reviewed publications.
Barton Haynes, global health professor and director of the Duke Human Vaccine Institute (DHVI), and colleagues from Duke and a number of collaborating institutions recently created an extraordinarily potent antibody that can neutralize 99.5% of the HIV strains tested—a significant advance in the fight against the disease.
Assistant professor of medicine and global health Gerald S. Bloomfield and 2015 Master of Science in Global Health alumna Melissa Burroughs Peña recently penned a commentary, “Five Reasons Why Global Health Matters to Cardiologists,” in the journal Cardiology Clinics, in which they reflect on how our global environment bears on the cardiology profession, particularly for cardiologists in high-income countries.
An op-ed by Ward Brehm and DGHI board chair Jack Leslie: We’ve seen the results firsthand. Americans would do well to understand the value of these investments—and oppose the proposed cuts.
In a first-of-its-kind study to look at the connection between child survival and the health system context, DGHI and Rice University researchers found that health care costs and the number and proximity of health facilities were major factors contributing to child survival in Kenya.
When Zika began to emerge as a potential epidemic, Barton Haynes, director of the Duke Human Vaccine Institute (DHVI), told the researchers in the DHVI’s Regional Biocontainment Laboratory to "get ready to face this epidemic.” This early preparation laid the groundwork for the rapid development and initial testing of a Zika candidate vaccine.
The Duke Global Health Institute (DGHI) and its Maternal, Adolescent and Child Health initiative are sponsoring a three-event speaker series featuring DGHI faculty members as well as guests from other institutions. Events will take place on March 23, March 27 and April 21
DGHI research scholar Dori Steinberg is the lead author on a Viewpoint piece published in last week’s Journal of the American Medical Association (JAMA) that examines why the 20-year-old DASH (short for Dietary Approaches to Stop Hypertension) diet hasn’t been widely adopted by individuals with high blood pressure.
In Uganda, where about 700,000 people are living with untreated epilepsy due to traumatic brain injuries and birth defects, there are only four neurologists who can treat the disease with medication. DGHI professor Michael Haglund is determined to change the game for Ugandan epilepsy patients, and he’s laying the groundwork with a new grant from the UCB Societal Responsibility Fund to establish the Uganda Epilepsy Centers of Excellence.